mucus relief
Generic: guaifenesin
Labeler: dolgencorp, inc. (dollar general & rexall)Drug Facts
Product Profile
Brand Name
mucus relief
Generic Name
guaifenesin
Labeler
dolgencorp, inc. (dollar general & rexall)
Dosage Form
TABLET
Routes
Active Ingredients
guaifenesin 600 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
55910-739
Product ID
55910-739_2f49161f-a4cf-4b5c-bc7d-dace78ee58e8
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA207342
Marketing Start
2019-03-31
Marketing End
2027-02-01
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55910739
Hyphenated Format
55910-739
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
mucus relief (source: ndc)
Generic Name
guaifenesin (source: ndc)
Application Number
ANDA207342 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 600 mg/1
Packaging
- 20 BLISTER PACK in 1 CARTON (55910-739-20) / 1 TABLET in 1 BLISTER PACK
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2f49161f-a4cf-4b5c-bc7d-dace78ee58e8", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0359726731201"], "unii": ["495W7451VQ"], "rxcui": ["636522"], "spl_set_id": ["32f58b4a-3e1b-424f-8296-a9bf9a7d7025"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "20 BLISTER PACK in 1 CARTON (55910-739-20) / 1 TABLET in 1 BLISTER PACK", "package_ndc": "55910-739-20", "marketing_end_date": "20270201", "marketing_start_date": "20190331"}], "brand_name": "Mucus Relief", "product_id": "55910-739_2f49161f-a4cf-4b5c-bc7d-dace78ee58e8", "dosage_form": "TABLET", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "55910-739", "generic_name": "Guaifenesin", "labeler_name": "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucus Relief", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "600 mg/1"}], "application_number": "ANDA207342", "marketing_category": "ANDA", "marketing_end_date": "20270201", "marketing_start_date": "20190331"}